InvestorsHub Logo
Followers 40
Posts 1805
Boards Moderated 0
Alias Born 07/26/2019

Re: north40000 post# 271048

Sunday, 05/03/2020 1:51:54 AM

Sunday, May 03, 2020 1:51:54 AM

Post# of 426504
North,
I too hope to see Vascepa included in these trials but we have to realize that the remdesivir population is a very sick one with advanced COVID-19 infection and with multiorgan failure. Thus, it is a big ask to expect Vascepa to save the day. I see a potentially bigger play in seeing if we can find asymptomatic or initially symptomatic serologically confirmed cases and see if we can prevent transmission or progression of disease. I feel this will give an altogether better therapeutic yield for detection of Vascepa benefits.
What is inexplicable to me is the tight lipped super hush - hush approach by both management and scientific leadership with vague allusions to understanding of V’s potential in COVID-19...What are they doing ?
HK
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News